NASDAQ:AWH
Aspira Women's Health Inc. Stock News
$2.29
-0.0400 (-1.72%)
At Close: May 24, 2024
Aspira Women's Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
08:00am, Wednesday, 06'th Dec 2023
Data supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometrioma
Aspira Women's Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)
08:00am, Tuesday, 28'th Nov 2023
California Medicaid (Medi-Cal) added Ova1Plus(R) to its fee schedule at $897 per test California Medicaid (Medi-Cal) added Ova1Plus(R) to its fee schedule at $897 per test
Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)
09:47am, Monday, 27'th Nov 2023
CMS approves OvaWatch SM 2024 price at $897 per test AUSTIN, Texas, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical
Aspira Women's Health Inc. (AWH) Q3 2023 Earnings Call Transcript
07:37pm, Monday, 13'th Nov 2023
Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2023 Earnings Call November 13, 2023 4:30 PM ET Company Participants Nicole Sandford - President and Chief Executive Officer Torsten Hombeck - Chief Financi
The proposed rule would allow for OvaWatch SM to be reimbursed at the same rate as Ova1 ® at $897 per test and will become final following a brief public comment period
Aspira Women's Health to Present at the BioVenture Nexus Conference
08:00am, Friday, 29'th Sep 2023
The conference is taking place on October 5-6, 2023, in Los Angeles, CA The conference is taking place on October 5-6, 2023, in Los Angeles, CA
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
11:17am, Thursday, 14'th Sep 2023
Here is how Aspira (AWH) and Compugen (CGEN) have performed compared to their sector so far this year.
All You Need to Know About Aspira (AWH) Rating Upgrade to Buy
01:35pm, Tuesday, 12'th Sep 2023
Aspira (AWH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Eleventh-Hour Climbers: 7 Stocks Gearing Up for a Late Summer Surge
04:11pm, Sunday, 03'rd Sep 2023
While some publicly traded enterprises left no doubt as to their trajectory, a few others are just now benefiting from a late summer stock surge. Better late than never, though.
Aspira Women's Health Inc. (AWH) Q2 2023 Earnings Call Transcript
09:14pm, Monday, 14'th Aug 2023
Aspira Women's Health Inc. (NASDAQ:AWH ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Nicole Sandford – President and Chief Executive Officer Torsten Hombeck –
Aspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
08:00am, Monday, 31'st Jul 2023
AUSTIN, Texas, July 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic t
AUSTIN, Texas, May 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Aspira (AWH) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.08 per share a year ago.
New Strong Buy Stocks for May 11th
09:10am, Thursday, 11'th May 2023
AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023.
Preliminary first quarter 2023 volume was 6,259 tests, an increase of 29% compared to last year, the highest volume quarter in the company's history
